VTRS News and Press, Viatris Inc. From 02/26/26

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

2026-02-25 10:34:55 ET More on Viatris Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation 44th Annual J.P. Morgan Healthcare Conference Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

2026-02-25 08:10:21 ET More on Viatris, Opus Genetics Opus Genetics: Asymmetric Upside With LCA5 And BEST1 Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation Opus Genetics, Inc. (IRD) Presents at 44th Annual J.P. Morgan Healthcare Co...

FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia PR Newswire FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH , Feb. 25, 2026 /PRNewswire/ --  Viatris Inc. (Nasdaq: VTRS), a g...

2026-02-22 08:07:08 ET The last week of February brings another packed stretch of earnings, with a mix of megacap technology leaders, consumer bellwethers, energy producers, financial firms, and high-growth disruptors set to report.... Read the full article on Seeking Alpha For ...

2026-02-21 12:30:27 ET More on S&P 500 Index This Is When Rising Oil Prices Become A Problem Tariff Decision Day? The Outlook For S&P 500 Dividends In February 2026 2025 real GDP growth was the softest in almost a decade, excluding COVID-19 Wa...

2026-02-21 07:00:09 ET Foreword Read the full article on Seeking Alpha For further details see: 24 Current Buys Fetched From Dogcatcher's 91 Top Dividend Dogs Over 10 Years

2026-02-20 15:09:00 ET ... Read the full article on Seeking Alpha For further details see: DFAT: Active Small Value ETF Beating Passive Competitors

NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, today announced that it will host a virtual key opinion leader (KOL) eve...

2026-02-17 17:27:10 ET More on PayPal, Pinterest, etc. PayPal: Despite Uncertainty, Stock Remains A Buy Pinterest: The Market Has Lost Its Mind, 25% Net Cash, Big Buybacks PayPal Vs. Fiserv: Which Is The Better Comeback Bet? SA Asks: Which financial stocks ar...